ADIPOR2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.128390E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.956830E-01
Normal-vs-Stage2
1.363880E-02
Normal-vs-Stage3
8.157400E-01
Normal-vs-Stage4
7.485700E-02
Stage1-vs-Stage2
5.189600E-02
Stage1-vs-Stage3
2.203200E-01
Stage1-vs-Stage4
7.585500E-02
Stage2-vs-Stage3
2.455900E-02
Stage2-vs-Stage4
5.241200E-01
Stage3-vs-Stage4
6.940100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.270370E-02
Normal-vs-AfricanAmerican
1.450820E-01
Normal-vs-Asian
9.200200E-01
Caucasian-vs-AfricanAmerican
1.860610E-01
Caucasian-vs-Asian
2.557800E-02
AfricanAmerican-vs-Asian
1.988170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.321500E-02
Normal-vs-Female
3.555800E-01
Male-vs-Female
6.989900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.579200E-01
Normal-vs-Age(41-60Yrs)
1.468800E-01
Normal-vs-Age(61-80Yrs)
3.565800E-02
Normal-vs-Age(81-100Yrs)
3.809200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.349600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.986100E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.044400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.243600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.167600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.712980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.770970E-01
Normal-vs-Daily Drinker
3.940600E-01
Normal-vs-Weekly Drinker
5.196000E-01
Normal-vs-Occasional Drinker
1.856040E-01
Normal-vs-Social Drinker
8.284400E-02
Non Drinker-vs-Daily Drinker
2.837400E-01
Non Drinker-vs-Weekly Drinker
2.905400E-01
Non Drinker-vs-Occasional Drinker
3.953800E-01
Non Drinker-vs-Social Drinker
6.538400E-01
Daily Drinker-vs-Weekly Drinker
9.889200E-01
Daily Drinker-vs-Occasional Drinker
2.438000E-01
Daily Drinker-vs-Social Drinker
2.278200E-01
Weekly Drinker-vs-Occasional Drinker
3.716600E-01
Weekly Drinker-vs-Social Drinker
2.507600E-01
Occasional Drinker-vs-Social Drinker
4.539000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.033600E-01
Normal-vs-Grade 2
5.312200E-01
Normal-vs-Grade 3
1.037220E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.354200E-01
Grade 1-vs-Grade 3
4.346800E-01
Grade 1-vs-Grade 4
7.033600E-01
Grade 2-vs-Grade 3
4.904400E-01
Grade 2-vs-Grade 4
5.312200E-01
Grade 3-vs-Grade 4
1.037220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.674000E-01
Normal-vs-NonDiabetic
1.911740E-02
Diabetic-vs-NonDiabetic
5.845400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.249200E-01
Normal-vs-NoPancreatitis
1.701780E-02
Pancreatitis-vs-NoPancreatitis
8.288600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.364430E-01
Normal-vs-N1
3.007600E-02
N0-vs-N1
8.129200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.660100E-02
Normal-vs-TP53-NonMutant
9.577600E-02
TP53-Mutant-vs-TP53-NonMutant
5.110600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
